In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies

Pharmaceutical Research

Volumn 21, Issue 12, 2004, Pages 2247-2252

  De Rosa, Fernanda Scarmato ^a,b   Vianna Lopez, Renata Fonseca ^a,b   Thomazine, José Antônio ^a   Tedesco, Antônio Cláudio ^a   Lange, Norbert ^c   Badra Bentley, Maria Vitóoria Lopes ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Lausanne ^*

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

5 ALA ester derivatives; 5 aminolevulinic acid; Photodynamic therapy; Protoporphyrin IX; Skin metabolism

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ALKALINITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG METABOLISM; EMULSION; ENZYME DEGRADATION; EXTRACTION; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN; STATISTICAL SIGNIFICANCE; TISSUE HOMOGENATE;

EID: 17644405513     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-004-7677-3     Document Type: Article

References (25)

1. J. C. Kennedy, R. H. Pottier, and D. C. Pross. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol. 6: 143-148 (1990).
2. F. S. De Rosa and M. V. L. B. Bentley. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm. Res. 17:1447-1455 (2000).
3. Q. Peng, K. Berg, J. Moan, M. Kongshaug, and J. M. Nesland. 5-aminolevulinic acid acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 65:235-251 (1997).
4. P. Wolf and H. Kerl. Photodynamic therapy with 5-aminolevulinic acid: a promising concept for the treatment of cutaneous tumors. Dermatology 190:183-185 (1995).
5. R. F. V. Lopez, N. Lange, R. Guy, and M. V. L. B. Bentley. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Del. Rev. 56:77-94 (2004).
6. J. Kloek, W. Akkermans, and G. M. J. B. Van Henegouwen. Derivatives of 5-aminolevulinic acid for Photodynamic Therapy: enzymatic conversion into protoporphyrin. Photochem. Photobiol. 67:150-154 (1998).
7. M. B. R. Pierre, A. C. Tedesco, J. M. Marchetti, and M. V. L. B. Bentley. Stratum corneum lipids liposomes for the topical delivery of 5- aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study, BMC Dermatol. 1:5, 2001. Available at http://www.biomedcentral.com/1471- 5945/1/5/
8. F. S. De Rosa, J. M. Marchetti, J. A. Thomazini, A. C. Tedesco, and M. V. L. B. Bentley. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J. Control. Rel. 65:359-366 (2000).
9. R. F. V. Lopez, M. V. L. B. Bentley, M. B. Delgado-Charro, and R. H. Guy. Iontophoretic delivery of 5- aminolevulinic acid (ALA): effect of pH. Pharm. Res. 18:311-315 (2001).
10. R. F. V. Lopez, M. V. L. B. Bentley, M. B. Delgado-Charro, D. Salomon, H. Van der Bergh, N. Lange, and R. H. Guy. Iontophoresis of 5-aminolevulinic acid esters: potential application in the photodynamic therapy of skin cancer? Photochem. Photobiol. 77:304-308 (2003).
11. L. Ma, J. Moan, Q. Peng, and V. Iani. Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colonadenocarcinoma of nude mice can be increased by ultrasound. Int. J. Cancer 78:464-469 (1998).
12. Q. Peng, J. Moan, T. Warloe, V. Iani, and H. B. Stenn. A. Bjørseth and J. M. Nesland. Buid-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin, J. Photochem. Photobiol. B. Biol 34:95-96 (1996).
13. N. Lange, P. Jichlinski, M. Zellweger, M. Forrer, A. Marti, L. Guillou, P. Kucera, G. Wagnieres, and H. Van Den Bergh. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br. J. Cancer 80:185-193 (1999).
14. A. Marti, N. Lange, H. Van den Bergh, A. Sedmera, P. Jichlinski, and P. Kucera. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J. Urol. 162:546-552 (1999).
15. P. Uehlinger, M. Zellweger, G. Wagnieres, L. Juillerat-Jeanneret, H. Van Der Berg, and N. Lange. 5-aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J. Photochem. Photobiol. B. Biol. 54:72-80 (2000).
16. J. Kloek and G. M. J. B. Van Henegouwen. Prodrugs of 5-aminolevulinic acid for Photodynamic Therapy. Photochem. Photobiol. 64:994-1000 (1996).
17. F. S. De Rosa, A. C. Tedesco, R. F. V. Lopez, M. B. R. Pierre, N. Lange, and J. M. Marchetti, J.C G. Rotta and M.V.L. Bentley. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivative for photodynamic therapy. J. Control. Rel. 89:261-269 (2003).
18. R. Causon. Validation of Chromatographic methods in biomedical analysis viewpoint and discussion. J. Chromatography B 689: 175-180 (1997).
19. M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
20. R. F. V. Lopez, J. H. Collett, and M. V. L. B. Bentley. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int. J. Pharm. 200:127-132 (2000).
21. J. Van Den Akker, V. Iani, W. Star, and H. Sterenborg, and J. Moan. Topical application of 5-aminolaevulinic acid hexyl ester and 5-aminolaevulinic to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem. Photobiol. 72:681-689 (2000).
22. A. Casas, H. Fukuda, G. Di Venosa, and A. Batlle. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization. Br. J. Cancer 85:1794-1800 (2001).
23. M. Zellweger, D. Goujon, R. Conde, M. Forrer, H. Vander Bergh, and G. Res. Absolute autofluorescence spectra of human healthy, metaplastic, and early cancerous bronchial tissue in vivo. Appl. Opt. 40:3784-3791 (2001).
24. H. Bando, M. Sahashi, T. Takagi, F. Yamashita, Y. Takakura, and M. Hashida. Analysis of in vitro skin penetration of acyclovir prodrugs based on a diffusion model with a metabolic process. Int. J. Pharm. 135:91-102 (1996).
25. T. Hikima and H. I. Maibach. Distribution of hydrolytic activity catalyzes the biotransformation of prednisolone 21-acetate in human skin. Skin Pharmacol. Appl. Skin Physiol. 14:196-202 (2001).